Marshall Wace, LLP Brainstorm Cell Therapeutics Inc. Transaction History

Marshall Wace, LLP

  • $63.3 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$2.0 - $3.2 $134,836 - $215,737
67,418 New
67,418 $138,000
Q4 2022

Feb 14, 2023
BUY
$1.37 - $3.39 $33,644 - $83,251
24,558 Added 188.56%
37,582 $61,000
Q3 2022

Nov 14, 2022
BUY
$2.55 - $4.3 $33,211 - $56,003
13,024 New
13,024 $58,000

Others Institutions Holding BCLI

# of Institutions
52
Shares Held
4.09M
Call Options Held
63.2K
Put Options Held
800
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $12.4M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email